Research Progress of Nanomaterial Drug Delivery in Tumor Targeted Therapy

Overview

Journal Front Bioeng Biotechnol

Date 2023 Aug 9

PMID 37555076

Authors

Peng Zhang

Guihua Ye

Guofeng Xie

Jie Lv

Xianhai Zeng

Wei Jiang

Affiliations

Soon will be listed here.

Abstract

Cancer is one of the most lethal diseases in human society, and its incidence is gradually increasing. However, the current tumor treatment often meets the problem of poor efficacy and big side effects. The unique physical and chemical properties of nanomaterials can target the delivery of drugs to tumors, which can improve the therapeutic effect while reducing the damage of drugs to normal cells. This makes nanomaterials become a hot topic in the field of biomedicine. This review summarizes the recent progress of nanomaterials in tumor targeted therapy.

Citing Articles

Nanomaterials: breaking the bottleneck of breast cancer drug resistance.

Guan C, Han Y, Ling Z, Meng X, Zhang B, Dong W Front Immunol. 2024; 15:1492546.

PMID: 39606228 PMC: 11599193. DOI: 10.3389/fimmu.2024.1492546.

References

Zhang Q, Wang F, Jia K, Kong L . Natural Product Interventions for Chemotherapy and Radiotherapy-Induced Side Effects. Front Pharmacol. 2018; 9:1253. PMC: 6232953. DOI: 10.3389/fphar.2018.01253. View

Centelles M, Wright M, So P, Amrahli M, Xu X, Stebbing J . Image-guided thermosensitive liposomes for focused ultrasound drug delivery: Using NIRF-labelled lipids and topotecan to visualise the effects of hyperthermia in tumours. J Control Release. 2018; 280:87-98. DOI: 10.1016/j.jconrel.2018.04.047. View

Robert J . [Biology of cancer metastasis]. Bull Cancer. 2013; 100(4):333-42. DOI: 10.1684/bdc.2013.1724. View

Khodadadei F, Safarian S, Ghanbari N . Methotrexate-loaded nitrogen-doped graphene quantum dots nanocarriers as an efficient anticancer drug delivery system. Mater Sci Eng C Mater Biol Appl. 2017; 79:280-285. DOI: 10.1016/j.msec.2017.05.049. View

Siegel R, Miller K, Fuchs H, Jemal A . Cancer statistics, 2022. CA Cancer J Clin. 2022; 72(1):7-33. DOI: 10.3322/caac.21708. View

Wang C, Wang J, Zhang X, Yu S, Wen D, Hu Q . In situ formed reactive oxygen species-responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy. Sci Transl Med. 2018; 10(429). DOI: 10.1126/scitranslmed.aan3682. View

Meric-Bernstam F, Johnson A, Dumbrava E, Raghav K, Balaji K, Bhatt M . Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer. Clin Cancer Res. 2018; 25(7):2033-2041. PMC: 6445731. DOI: 10.1158/1078-0432.CCR-18-2275. View

Galliani M, Tremolanti C, Signore G . Nanocarriers for Protein Delivery to the Cytosol: Assessing the Endosomal Escape of Poly(Lactide-co-Glycolide)-Poly(Ethylene Imine) Nanoparticles. Nanomaterials (Basel). 2019; 9(4). PMC: 6523739. DOI: 10.3390/nano9040652. View

Alavi M, Hamidi M . Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles. Drug Metab Pers Ther. 2019; 34(1). DOI: 10.1515/dmpt-2018-0032. View

10.

Zheng R, Zhang S, Zeng H, Wang S, Sun K, Chen R . Cancer incidence and mortality in China, 2016. J Natl Cancer Cent. 2024; 2(1):1-9. PMC: 11256658. DOI: 10.1016/j.jncc.2022.02.002. View

11.

Simard J, Durocher I, Girard D . Silver nanoparticles induce irremediable endoplasmic reticulum stress leading to unfolded protein response dependent apoptosis in breast cancer cells. Apoptosis. 2016; 21(11):1279-1290. DOI: 10.1007/s10495-016-1285-7. View

12.

Sanita G, Carrese B, Lamberti A . Nanoparticle Surface Functionalization: How to Improve Biocompatibility and Cellular Internalization. Front Mol Biosci. 2020; 7:587012. PMC: 7726445. DOI: 10.3389/fmolb.2020.587012. View

13.

van Wamel A, Sontum P, Healey A, Kvale S, Bush N, Bamber J . Acoustic Cluster Therapy (ACT) enhances the therapeutic efficacy of paclitaxel and Abraxane® for treatment of human prostate adenocarcinoma in mice. J Control Release. 2016; 236:15-21. DOI: 10.1016/j.jconrel.2016.06.018. View

14.

Wang K, Cai Z, Fan R, Yang Q, Zhu T, Jiang Z . A tumor-microenvironment-responsive nanomaterial for cancer chemo-photothermal therapy. RSC Adv. 2022; 10(37):22091-22101. PMC: 9054608. DOI: 10.1039/d0ra04171h. View

15.

Saito M, Suzuki H, Kono K, Takenoshita S, Kohno T . Treatment of lung adenocarcinoma by molecular-targeted therapy and immunotherapy. Surg Today. 2017; 48(1):1-8. DOI: 10.1007/s00595-017-1497-7. View

16.

Lu Y, Lin P, Huang P, Kuo C, Shalumon K, Chen M . Magnetic Graphene Oxide for Dual Targeted Delivery of Doxorubicin and Photothermal Therapy. Nanomaterials (Basel). 2018; 8(4). PMC: 5923523. DOI: 10.3390/nano8040193. View

17.

Matbou Riahi M, Sahebkar A, Sadri K, Nikoofal-Sahlabadi S, Jaafari M . Stable and sustained release liposomal formulations of celecoxib: In vitro and in vivo anti-tumor evaluation. Int J Pharm. 2018; 540(1-2):89-97. DOI: 10.1016/j.ijpharm.2018.01.039. View

18.

Wu P, Liu Q, Li R, Wang J, Zhen X, Yue G . Facile preparation of paclitaxel loaded silk fibroin nanoparticles for enhanced antitumor efficacy by locoregional drug delivery. ACS Appl Mater Interfaces. 2013; 5(23):12638-45. DOI: 10.1021/am403992b. View

19.

Lopez-Davila V, Seifalian A, Loizidou M . Organic nanocarriers for cancer drug delivery. Curr Opin Pharmacol. 2012; 12(4):414-9. DOI: 10.1016/j.coph.2012.02.011. View

20.

Carrion C, Nasrollahzadeh M, Sajjadi M, Jaleh B, Jamalipour Soufi G, Iravani S . Lignin, lipid, protein, hyaluronic acid, starch, cellulose, gum, pectin, alginate and chitosan-based nanomaterials for cancer nanotherapy: Challenges and opportunities. Int J Biol Macromol. 2021; 178:193-228. DOI: 10.1016/j.ijbiomac.2021.02.123. View